These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2441239

  • 1. Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells.
    Nakashima H, Harada S, Yamamoto N.
    Med Microbiol Immunol; 1987; 176(4):189-98. PubMed ID: 2441239
    [Abstract] [Full Text] [Related]

  • 2. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
    Yamamoto N, Harada S, Nakashima H.
    AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
    Nakashima H, Matsui T, Harada S, Kobayashi N, Matsuda A, Ueda T, Yamamoto N.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
    Harada S, Koyanagi Y, Nakashima H, Kobayashi N, Yamamoto N.
    Virology; 1986 Oct 30; 154(2):249-58. PubMed ID: 3639669
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
    Ito M, Nakashima H, Baba M, Pauwels R, De Clercq E, Shigeta S, Yamamoto N.
    Antiviral Res; 1987 Mar 30; 7(3):127-37. PubMed ID: 3475037
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of human immunodeficiency virus type I reverse transcriptase by suramin-related compounds.
    Jentsch KD, Hunsmann G, Hartmann H, Nickel P.
    J Gen Virol; 1987 Aug 30; 68 ( Pt 8)():2183-92. PubMed ID: 2440983
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H, Tochikura T, Kobayashi N, Matsuda A, Ueda T, Yamamoto N.
    Virology; 1987 Jul 30; 159(1):169-73. PubMed ID: 3111083
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 1 beta and interleukin 6 potentiate retinoic acid-mediated repression of human immunodeficiency virus type 1 replication in macrophages.
    Brown XQ, Hanley TM, Viglianti GA.
    AIDS Res Hum Retroviruses; 2002 Jun 10; 18(9):649-56. PubMed ID: 12079560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.